ADA 2019
ADA 2019
Canagliflozin Effective in Improving Cardiovascular, Renal Outcomes in People with T2D
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new subgroup analysis from the phase 3 CREDENCE study,
Consistent Use of Diabetes Technology At School, Day Camp Can Benefit Youth with Diabetes
In recent years, diabetes technology has evolved at a rapid pace.
Low-Calorie Diet, Weight Management Effective in Lowering T2D Risk
Data from 2 studies noted no differences between either program. 
Study: Vitamin D Supplementation Does Not Effectively Drop T2D Risk
Researchers did not find a statistically significant benefit in using vitamin D to decrease the likelihood of developing type 2 diabetes in high risk individuals.